Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
September 30, 2026 0.0177M
June 30, 2026 -6.421M
March 31, 2026 156.57M
December 31, 2025 93.64M
September 30, 2025 0.00
June 30, 2025 -0.073M
March 31, 2025 0.00
December 31, 2024 -0.1725M
September 30, 2024 -0.0896M
June 30, 2024 0.00
March 31, 2024 0.2217M
December 31, 2023 -0.0985M
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.4099M
September 30, 2022 0.5691M
June 30, 2022 14.09M
March 31, 2022 29.95M
December 31, 2021 161.84M
September 30, 2021 0.1852M
June 30, 2021 23.99M
March 31, 2021 1.928M
December 31, 2020 0.9442M
September 30, 2020 1.634M
Date Value
June 30, 2020 22.89M
March 31, 2020 3.005M
June 30, 2019 10.83M
March 31, 2019 1.639M
December 31, 2018 4.687M
September 30, 2018 0.3195M
June 30, 2018 0.2573M
March 31, 2018 -0.0567M
December 31, 2017 2.387M
September 30, 2017 3.956M
June 30, 2017 -0.0276M
March 31, 2017 -0.0824M
December 31, 2016 -0.0544M
September 30, 2016 -0.1092M
June 30, 2016 0.00
March 31, 2016 -0.0885M
December 31, 2015 -0.0879M
September 30, 2015 -0.0873M
June 30, 2015 0.0062M
March 31, 2015 -0.0281M
December 31, 2014 9.018M
September 30, 2014 4.159M
August 31, 2014
May 31, 2014
February 28, 2014 -2.801M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Talphera, Inc. 0.032M
Journey Medical Corp. 0.117M
ANI Pharmaceuticals, Inc. -9.829M
Corcept Therapeutics, Inc. -23.88M
Veru, Inc. -0.0519M